Kodiak Sciences, Inc. (KOD)
37.73
-1.39
(-3.56%)
USD |
NASDAQ |
Aug 28, 16:00
37.73
0.00 (0.00%)
After-Hours: 18:01
Kodiak Sciences Shareholders Equity (Quarterly) : 61.10M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 61.10M |
| March 31, 2026 | 112.10M |
| December 31, 2025 | 157.38M |
| September 30, 2025 | 23.69M |
| June 30, 2025 | 70.29M |
| March 31, 2025 | 108.84M |
| December 31, 2024 | 150.29M |
| September 30, 2024 | 185.37M |
| June 30, 2024 | 214.51M |
| March 31, 2024 | 241.19M |
| December 31, 2023 | 265.78M |
| September 30, 2023 | 302.42M |
| June 30, 2023 | 338.48M |
| March 31, 2023 | 392.59M |
| December 31, 2022 | 436.17M |
| September 30, 2022 | 479.53M |
| June 30, 2022 | 530.93M |
| March 31, 2022 | 597.38M |
| Date | Value |
|---|---|
| December 31, 2021 | 663.32M |
| September 30, 2021 | 726.32M |
| June 30, 2021 | 779.43M |
| March 31, 2021 | 821.68M |
| December 31, 2020 | 860.75M |
| September 30, 2020 | 281.78M |
| June 30, 2020 | 309.20M |
| March 31, 2020 | 327.69M |
| December 31, 2019 | 345.36M |
| September 30, 2019 | 59.69M |
| June 30, 2019 | 70.02M |
| March 31, 2019 | 80.10M |
| December 31, 2018 | 86.83M |
| September 30, 2018 | -43.81M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -18.72M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 256.81M |
| Total Liabilities (Quarterly) | 195.72M |
| Debt to Equity Ratio | 2.500 |
| Current Ratio | 2.489 |
| Net Debt Paydown Yield | 0.12% |